Assessment of the impact of FcγRIIIA single-nucleotide polymorphisms on the efficacy of IgG1 monoclonal antibodies in patients with advanced gastroesophageal adenocarcinoma
-
Published:2023-12
Issue:
Volume:2
Page:100012
-
ISSN:2949-8198
-
Container-title:ESMO Gastrointestinal Oncology
-
language:en
-
Short-container-title:ESMO Gastrointestinal Oncology
Author:
Serritella A.V.ORCID,
Grewal N.K.S.ORCID,
Peterson B.,
Arndt K.,
Gaudio D.D.,
Liu P.,
Shergill A.,
Polite B.,
Kindler H.L.,
Catenacci D.V.T.,
Liao C.Y.ORCID